Resources for Health Professionals

Interested in Assistance?
Medical Care Services' Health Professionals Outreach & Education shares information on clinical guidelines, community resources and other services to support you and your practice. Please contact us at MCS@sdcounty.ca.gov.
Join the Health Professionals telebriefing on the 1st Thursday of the month at 3:30 pm. CME and Dental CE will be provided!
Register to receive invitations to the Health Professionals telebriefings, eBlasts, and newsletters.
-
Avian Influenza (H5N1 Bird Flu)
The H5 Avian Influenza virus, commonly known as bird flu, is widespread in the wild bird population and has caused infections in poultry, wild, and domestic mammals, (e.g., cattle and cats). Most human infections with bird flu have occurred after unprotected exposure to sick or dead infected poultry or dairy cattle.
The majority of human illnesses have been mild (e.g., upper respiratory symptoms, conjunctivitis), with rare significant cases (e.g., pneumonia, multi-organ failure), and one death.
At this time, the CDC considers the health risk to the U.S. public to be low; however, people with close or prolonged, unprotected exposures to infected individuals, birds, or other animals, or to environments contaminated by infected birds or other animals, are at greater risk of infection.
CDC considers bird flu viruses to have the potential to cause severe disease in infected humans and recommends:
- Clinicians should consider the possibility of bird flu in persons showing signs or symptoms of acute respiratory illness or conjunctivitis who have relevant exposure history or recent consumption of raw dairy products
- Expedited subtyping of influenza A-positive specimens from hospitalized patients, particularly those in an intensive care unit (ICU).
Antiviral treatment is recommended as soon as possible for patients suspected or confirmed to have avian influenza A infection. Antiviral prophylaxis is recommended for close (e.g., household) contacts of infected persons. Treatment should not be delayed while waiting for laboratory test results.
If you suspect exposure to bird flu, contact the San Diego County Epidemiology line at (619) 692-8499 (Monday - Friday 8 AM -5 PM or (858) 565-5255 (after hours and holidays) to determine next steps.
Please see the County of San Diego Bird Flu (Avian Influenza) Information for Health Care Professionals website for additional details on Specimen Collection, Treatment, and Infection Prevention and Control.
If you find a dead bird, (Crow, Raven, Jay, Hawk, Owl, or Falcon) contact Vector Control at (858) 694-2888, Mon-Fri 8:00 am - 5:00 pm; (858) 505-6657, weekends, holidays, or outside business hours or email vector@sdcounty.ca.gov during business hours (8am-5pm, M-F only).
Additional Resources:
-
COVID-19 Treatment Information and Educational Material
Early treatment of mild to moderate COVID-19 is standard of care to reduce hospitalizations, deaths and Long COVID, and must be started within 5-7 days of symptom onset to be effective.
COVID-19 Testing: Get a home COVID-19 test and find a test site near you.
- Treatment Locator for COVID-19 medications
- Contact your primary care physician for treatment as soon as possible. You can call 211 to find a physician if you do not have one.
- Call Sesame Care at 1-888-897-1244 to schedule telehealth visit. Use Code CACOVID for discounted rate.
Treatment Flyers for Providers
- COVID-19 Therapeutics: Resources for Health Care Professionals and Public Health Officials (ASPR)
- Side-by-Side Overview of Therapeutics for Mild to Moderate COVID-19 (ASPR)
- Paxlovid Information and FAQs (ASPR)
- Lagevrio (Molnupiravir) (ASPR)
- Veklury (remdesivir) (ASPR)
Additional Links for Patients
County of San Diego COVID-19 Treatment for the Public
County of San Diego COVID-19 Outpatient Therapies
Additional Links
COVID-19 for Health Professionals
COVID-19 Educational Materials
COVID-19 Protect Yourself and Your Family
Preparation for Respiratory Virus Season (COVID-19, Influenza and RSV) (UPDATED)
-
Fluoride Varnish Application Toolkit
Pediatricians and office staff play an important role in preventing dental caries in children. This toolkit will support the implementation of fluoride varnish applications in a primary care setting.
This toolkit was created through a collaborative effort by the Healthy San Diego Quality Improvement Committee and the County of San Diego, Public Health Services and Medical Care Services.
Introduction
The purpose of this toolkit is to support the implementation of fluoride varnish applications in a primary care setting.
Letter from County of San Diego Chief Dental Officer and Medical Director
Purpose of This Toolkit and How to Use It
Getting Started
The documents in this section will provide you and your staff with the tools needed to create a fluoride varnish protocol specific to your office including:
Fluoride Varnish Application: 9-Step Quick Reference
Fluoride Varnish Application: Office Protocol
Medical Provider Resources
Documents in this section cover the requirements and recommendations to provide early screenings, treatment, and referrals for oral health and continued dental care including:
Oral Health Risk Assessment Tool
Staff Resources
The following resources can be used by staff to educate families and refer them to a dental home:
List of Community Dental Clinics
Supporting Evidence
The documents in this section support and justify the implementation of fluoride varnish in a medical setting:
California Oral Health Plan at a Glance
Is Fluoride Varnish Safe? Validating the Safety of Fluoride Varnish
Age of First Dental Visits: A Benefit of the Pediatric Medical Home
Training Resources
The materials in this section were used during virtual Oral Health and Fluoride Varnish Application trainings:
-
Mental Health & Substance Use Resources
Caring For Your Mental Health During COVID-19 For Healthcare Personnel
Carry Naloxone to Prevent Overdose
National Alliance on Mental Health
National Alliance on Mental Illness Warmline
Recovery International San Diego
San Diego Access & Crisis Line (or call 988)
Survivors of Suicide Loss San Diego
Xylazine Information for Health Professionals
-
Mpox Resources
Have a heightened suspicion for clade I MPXV for patients with mpox-like symptoms or probable/confirmed MPXV infection who have been in affected Central or Eastern African countries in the previous 21 days and/or have had close or intimate contact with symptomatic people who have been in those countries.
Follow infection prevention and control recommendations for all patients with mpox symptoms.
Immediately report probable, suspected, and confirmed clade I MPXV cases to the County of San Diego Health and Human Services Agency as soon as possible and no later than 24 hours after diagnosis by submitting a Confidential Morbidity Report by fax to (619) 692-8541 or by secure e-mail to phs-hshb-stdreportingfax.hhsa@sdcounty.ca.gov.
Test for clade I MPXV by submitting clinical specimens for clade-specific MPXV testing if clade I MPXV is suspected. General (i.e., clade-nonspecific) MPXV testing is available through commercial laboratories and the San Diego County Public Health Laboratory (SDCPHL). If clade I MPXV is suspected, refer to SDCPHL Guidelines to obtain approval for clade-specific MPXV testing and for detailed instructions on sample collection, storage, and transport.
Encourage vaccination for people who are vulnerable to mpox or who request the vaccine, particularly for people with weakened immune systems due to human immunodeficiency virus (HIV) infection or other conditions, as they are at risk for severe disease.
The Advisory Committee on Immunization Practices (ACIP) recommends vaccination for people aged 18 years or older who may be at risk for mpox, which now includes people who are traveling to countries with ongoing person-to-person transmission of clade I MPXV who anticipate sexual activities, with two doses of the JYNNEOS vaccine (at least 28 days apart).
JYNNEOS may also be given as post-exposure prophylaxis to asymptomatic persons ideally within four days but up to 14 days after exposure if they have not already received two doses of the vaccine or been previously infected with MPXV.
Further information regarding vaccine eligibility is available through the CDC.
Currently there is no treatment approved for MPXV infections. For most patients with mpox who do not have severe disease or risk factors for severe disease (e.g., severe immunocompromise), supportive care and pain control will help them recover.
Interim clinical guidance developed by CDC may assist clinicians in managing patients with protracted or life-threatening manifestations of mpox. Treatment for these patients involves Food and Drug Administration (FDA)–regulated drugs and biologics that are primarily stockpiled by the U.S. government.
For any questions or to report a suspected case please contact the Epidemiology Unit by phone at (619) 692-8499. For urgent matters on evenings, weekends or holidays, dial (858) 565-5255 and ask for the Epidemiology Unit duty officer.
Additional Resources
Mpox Webpage | County of San Diego
CDC Clinical Overview of Mpox | CDC December 11, 2024
Mpox in the United States and Around the World: Current Situation | CDC January 8, 2025
Page last updated 3/3/2025

How are we doing? Please take a moment to provide your feedback and help us serve you better with our new HEART survey! County of San Diego Customer Experience Survey